Otitis%20media%20-%20acute%20(pediatric) Patient Education

Patient Education

Advise parent/caregiver on preventable risk factors
Pain must be addressed regardless of the need for antibacterial agents, especially in the first 24 hours of illness
Review the risks (eg side effects, antibiotic resistance in the community)

Immunotherapy sparks hope for paediatric ALL

Audrey Abella, 14 Oct 2020

Despite a 90-percent cure rate after first treatment for children with acute lymphoblastic leukaemia (ALL), approximately 10–15 percent of patients with paediatric ALL will experience relapse. [Expert Rev Anticancer Ther 2017;17:725-736] A recent webinar on the current landscape of ALL highlighted the potential of immunotherapy for paediatric patients with relapsed or refractory ALL, thus providing hope for this high-risk patient group.

Gangliosides and cognition: An appraisal of the evidence

01 Sep 2018

Gangliosides and docosahexaenoic acid (DHA) play critical roles in early childhood brain development.

Navigating the CPP patient journey – case-based discussion for nurses

06 May 2021

In a webinar held on 27 March 2021, paediatric endocrinology nurses Karen Blair, Kate Davies, and Siti Zarina Yaakop shared insights and clinical experience based on their frontline roles in caring for patients with central precocious puberty (CPP) and supporting their family members.